Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Prostate
Study Phase
Phase 3
Study Completion Date
July 2012
NCT00079001Uploaded 07-07-2018
Access via NCI by Request
PDS UID - nci-data-373
A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone
Files: NCT00079001-D3
Data DictionaryNCT00079001-D3-Data-Dictionary.pdf
DATANCT00079001-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT00079001-D2
Data DictionaryNCT00079001-D2-Data-Dictionary.pdf
DATANCT00079001-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00079001-D1
Data DictionaryNCT00079001-D1-Data-Dictionary.pdf
DATANCT00079001-D1-Dataset.csv
OTHERREADME.pdf